Nathalie Machluf, PhD

Senior Director Regulatory Affairs
SciVac Ltd
Rehovot, HaMerkaz, Israel

Disclosure: SciVac Ltd: Employee

Presentation(s):

• LB13 - Trivalent hepatitis B (HepB) vaccine yields superior seroprotection rates in adults: results from the phase 3 double-blind, randomized study comparing immunogenicity and safety of a 3-dose regimen of Sci-B-Vac™ and Engerix B®(PROTECT)

  Friday, October 4
  2:35 PM – 2:45 PM